Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques

Concerns that the injectable contraceptive depot-medroxyprogesterone acetate (DMPA) may increase the risk of HIV acquisition in women led to questions on whether DMPA could reduce efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention. We used a macaque model to investigate the impact of pro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Radzio, Jessica, Hanley, Krisztina, Mitchell, James, Ellis, Shanon, Deyounks, Frank, Jenkins, Leecresia, Heneine, Walid, Garcia-Lerma, J. Gerardo
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4213266/
https://ncbi.nlm.nih.gov/pubmed/25202923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000340
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi